Unpredictable high-dollar claims are putting a strain on resources and creating an uneven playing field for providers. PayRx offers solutions for financial and clinical management. Backed by a panel of global (re)insurers and banks, PayRx delivers large-scale, custom solutions, within the healthcare industry.
Learn More About Who We Help
However, as healthcare costs continue to rise, payers are increasingly struggling to cover the expense of high-dollar drug claims. In particular, gene and cell therapies hold great promise for treating a wide range of diseases.
Gene and Cell Therapies are revolutionizing healthcare. By 2050 approximately 50 to 60 new drug approvals will be granted, with an average price of $250k-$2M per approval!
Healthcare payers are poised to spend an additional $240 billion on new high cost advanced personalized medical therapies coming to the market.
PayRx provides a vital service that helps healthcare payers avoid negative reactive assessments for lifesaving and life changing advanced therapeutics because of high-costs.
We understand the importance of planning for high-dollar claims, which is why we offer on demand risk financing to help you pay unplanned expenses.
With our analytics, you can keep your eye on the future and plan for therapies with confidence.
Working with the world's leading banks, we provide tailor-made financing solutions for payers, for the most advanced therapies.
We are committed to helping the most vulnerable populations. Our focus is on life-saving therapies and ensuring that our patients get what they need from us, no matter their condition or location in society.
